France · Delayed Price · Currency is EUR bioMérieux Company Description
bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions.
The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer.
Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries.
Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities.
Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
| Country | France |
| Founded | 1963 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 15,226 |
| CEO | Pierre Boulud |
Contact Details
Address: 376 Chemin De l’Orme Marcy-l'Étoile France | |
| Phone | 33 4 78 87 20 00 |
Stock Details
| Ticker Symbol | BIM |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0013280286 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Pierre Boulud | Chief Executive Officer |
| Guillaume Bouhours | Executive Vice President of Finance, Purchasing and Information Systems and Chief Financial Officer |
| Aymeric Fichet | Head of Investor Relations |
| Audrey Dauvet | Executive Vice President of Legal, Corporate Integrity and Public Affairs |
| Valerie Leylde | Executive Vice President of Human Resources, Communications and CSR |
| Pierre Charbonnier | Executive Vice President of Global Quality, Manufacturing and Supply Chain |
| Yasha Mitrotti | Executive Vice President of Industrial Applications |
| Frederic Beseme | Head of CSR |
| Jennifer Zinn | Executive Vice President of Clinical Operations |
| Dr. Charles K. Cooper | Executive Vice President of Medical Affairs and Chief Medical Officer |